CBDBY yields 301.09% · JNJ yields 2.13%● Live data
📍 CBDBY pulled ahead of the other in Year 1
Combined, CBDBY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CBDBY + JNJ for your $10,000?
Companhia Brasileira de Distribuição engages in the retail of food, clothing, home appliances, electronics, and other products through its chain of supermarkets, specialized stores, and department stores in Brazil. It operates in Brazilian Retail, Grupo Éxito, and Other Businesses segments. The company sells non-perishables, beverages, fruits, vegetables, meat, breads, cold cuts, dairy products, cleaning products, disposable products, and personal care products; and home appliances and other non-food products, such as clothing and baby items, shoes and accessories, household articles, books, magazines, CDs and DVDs, stationery, toys, sports and camping gears, furniture, mobile phones, mattresses, pet products, and gardening equipment and tools, as well as electronic products, including personal computers, software, computer accessories, and sound and image systems. It also offers medications and cosmetics at its drugstores; and non-food products at gas stations, as well as rents commercial spaces and e-commerce sales. The company operates its supermarkets under the banners of Pão de Açúcar, Extra Supermercado, Mercado Extra, and Compre Bem; hypermarkets under the banner of Extra Hiper; and proximity stores under the banners of Mini Extra, Minuto Pão de Açúcar, Pão de Açúcar Adega, and Aliados Minimercado; and gas stations and drugstores under the banners of Extra and Pão de Açúcar, as well as sells its products through its Websites. As of December 31, 2021, it operated 667 stores, 74 gas stations, and 68 drugstores in 16 Brazilian states and the Federal District, as well as 15 distribution centers and warehouses across Brazil. The company was founded in 1948 and is headquartered in São Paulo, Brazil.
Full CBDBY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.